The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

It might even have the ability to predict who will get dementia. An AI computer program that analyzes speech patterns in ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...

First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...

Johnson & Johnson is advancing Alzheimer’s research through precision medicine, focusing on tau-targeting therapies like ...

A SIMPLE blood test that could catch dementia before major symptoms start has begun trials in NHS clinics. More than 3,000 ...

PEOPLE often think of Alzheimer’s when they think of dementia. It’s the most common type of dementia, accounting for 60-80 ...

Prolonged rapid eye movement sleep latency may be an early indicator of Alzheimer’s disease and related dementias, according ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

The FDA has granted medical manufacturer Beckman Coulter a Breakthrough Device Designation for its new plasma ratio, a blood ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The research teams will build on recent breakthroughs in dementia blood tests, generating the evidence needed for them to be used in the NHS to improve diagnosis of dementia. Professor Fiona Carragher ...